Dan Spiegelman

Board Member at Opthea - South Yarra, VIC, AU

Dan Spiegelman's Contact Details
HQ
61-3-9826-0399
Location
Palo Alto,California,United States
Company
Opthea
Dan Spiegelman's Company Details
Opthea logo, Opthea contact details

Opthea

South Yarra, VIC, AU • 20 - 49 Employees
BioTech/Drugs

Opthea is a clinical stage biopharmaceutical company committed to developing innovative therapies to help improve visual function in patients suffering with retinal diseases. Our first in class novel therapeutic called OPT-302, is a VEGF-C/D ‘trap', to be used in combination with existing standard of care anti-VEGF-A therapies to improve vision in patients, many of whom respond sub-optimally or become refractory to existing treatments. Millions of people around the world suffer from impaired vision as a result of diabetes and old age. Our mission is to improve vision leading to a better quality of life. Enquiries can be directed to: info@opthea.com

Ophthalmological drug development
Details about Opthea
Frequently Asked Questions about Dan Spiegelman
Dan Spiegelman currently works for Opthea.
Dan Spiegelman's role at Opthea is Board Member.
Dan Spiegelman's email address is ***@opthea.com. To view Dan Spiegelman's full email address, please signup to ConnectPlex.
Dan Spiegelman works in the Research industry.
Dan Spiegelman's colleagues at Opthea are Judy Robertson, Mike Gerometta, Mark Oneill, Megan Baldwin, Annette Leahy, Clare Price, Richard Chadwick and others.
Dan Spiegelman's phone number is 61-3-9826-0399
See more information about Dan Spiegelman